Recurrent Salivary Gland Cancer

Also known as: Salivary gland cancer recurrent / Malignant salivary gland cancer recurrent

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB019337-Hydroxystaurosporine1Completed1
DB12442Alvespimycin1Completed1
DB00112Bevacizumab1Completed1
DB00958Carboplatin1Completed1
DB00958Carboplatin1Recruiting1
DB00958Carboplatin1Terminated1
DB00002Cetuximab1Completed3
DB00002Cetuximab1Terminated1
DB00515Cisplatin1Completed1
DB01248Docetaxel1Completed1
DB00530Erlotinib1Completed2
DB00530Erlotinib1Withdrawn1
DB01590Everolimus1Completed1
DB01590Everolimus1Withdrawn1
DB00099Filgrastim1Completed1
DB00544Fluorouracil1Completed1
DB00544Fluorouracil1Recruiting1
DB01005Hydroxyurea1Completed1
DB01005Hydroxyurea1Recruiting1
DB00762Irinotecan1Completed1
DB12117Mitometh1Completed1
DB12303Motolimod1Completed1
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Recruiting1
DB01229Paclitaxel1Terminated1
DB00020Sargramostim1Completed1
DB00398Sorafenib1Completed1
DB01268Sunitinib1Terminated1
DB00072Trastuzumab1Completed1
DB02546Vorinostat1Terminated1
DB00112Bevacizumab1 / 2Completed1
DB00002Cetuximab1 / 2Active Not Recruiting1
DB00002Cetuximab1 / 2Completed1
DB01248Docetaxel1 / 2Completed1
DB00530Erlotinib1 / 2Completed2
DB09150Fludeoxyglucose F-181 / 2Active Not Recruiting1
DB09502Fludeoxyglucose F-181 / 2Active Not Recruiting1
DB00112Bevacizumab2Completed1
DB00188Bortezomib2Completed1
DB01101Capecitabine2Completed1
DB00958Carboplatin2Completed1
DB00002Cetuximab2Completed2
DB01254Dasatinib2Completed2
DB00997Doxorubicin2Completed1
DB04940Eribulin2Completed1
DB08871Eribulin2Completed1
DB00530Erlotinib2Completed1
DB06188Ispinesib2Completed1
DB04845Ixabepilone2Completed1
DB01259Lapatinib2Completed3
DB01229Paclitaxel2Completed1
DB00398Sorafenib2Completed2
DB00072Trastuzumab2Terminated1
DB06151AcetylcysteineNot AvailableActive Not Recruiting1
DB00317GefitinibNot AvailableCompleted1